Control_Guth_20_S24_L002_R1_001.fastq.gz

syn30250476

Created By Elliot Stieglitz estieglitz

age: 0
sex: Unknown
Uuid: 3e563190-5959-4faa-b813-f58d7a23433f
assay: bisulfite sequencing
organ:
tissue: blood
ageUnit: months
runType: pairedEnd
species: Homo sapiens
studyId: syn51133946
comments:
dataType: chromatin activity
entityId: syn30250476
platform: Illumina NovaSeq 6000
readPair: 1
Component: EpigeneticsAssayTemplate
aliquotID:
diagnosis:
readDepth:
studyName: DHART SPORE Project 3 - A High Content Clinical Trial (ADVL1521) of the MEK Inhibitor Trametinib in Juvenile Myelomonocytic Leukemia (JMML), a Phase II clinical trial
tumorType: Not Applicable
fileFormat: fastq
initiative: DHART-SPORE Project 3
isCellLine: No
readLength: 150
specimenID: Control_Guth_20
assayTarget:
dataSubtype: raw
nf1Genotype: -/-
nf2Genotype: -/-
individualID: Control_Guth_20
resourceType: experimentalData
fundingAgency: NIH-NCI
isPrimaryCell: Yes
timePointUnit:
parentSpecimenID: Control_Guth_20
nucleicAcidSource: bulk cell
dissociationMethod:
genePerturbationType: Not Applicable
experimentalTimepoint:
specimenPreparationMethod:
genePerturbationTechnology:

Control_Guth_20_S24_L002_R1_001.fastq.gz page is loading…